Zarontin Drug Interactions: What to Avoid and What to Tell Your Doctor

Zarontin (ethosuximide) is primarily metabolized by the CYP3A4 enzyme system in the liver, making it susceptible to interactions with many commonly used medications. Understanding these interactions is critical to maintaining seizure control and avoiding toxicity.

This guide covers the most clinically significant interactions and what you should tell your prescriber before starting any new medication.

How Does Zarontin Interact With Other Drugs?

Ethosuximide is a sensitive substrate of the CYP3A4 enzyme system—meaning its blood levels are significantly affected by other drugs that speed up or slow down this enzyme. The two main categories of interaction:

• CYP3A4 inducers — Drugs that speed up CYP3A4 will increase the breakdown of ethosuximide, potentially reducing its blood levels and decreasing seizure control.
• CYP3A4 inhibitors — Drugs that slow down CYP3A4 will decrease the breakdown of ethosuximide, potentially increasing its blood levels and causing toxicity.

Interactions With Other Antiseizure Medications

• Valproic acid (Depakote): Can both increase AND decrease ethosuximide levels depending on the situation. This variability requires careful monitoring when the two drugs are used together. Valproic acid can also increase ethosuximide toxicity. Periodic serum level checks are recommended.
• Phenytoin (Dilantin): Ethosuximide may elevate phenytoin serum levels, potentially causing phenytoin toxicity (ataxia, nystagmus, confusion). Monitor phenytoin levels when adding or adjusting ethosuximide. Phenytoin can also reduce ethosuximide levels by inducing CYP3A4.
• Carbamazepine (Tegretol) and Phenobarbital: Both are strong CYP3A4 inducers. They can significantly reduce ethosuximide blood levels, potentially causing breakthrough absence seizures. Dose adjustments may be needed if these are prescribed together.
• Lamotrigine: Ethosuximide may reduce lamotrigine blood levels by approximately 37% in children, which could reduce lamotrigine efficacy. More research is needed, but monitoring is advisable when both drugs are used together.

Interactions That Can Increase Ethosuximide Levels (Risk of Toxicity)

The following drugs inhibit CYP3A4 and can increase ethosuximide levels. Avoid or use with extreme caution:

• Adagrasib (Krazati) — A CYP3A4 inhibitor; avoid coadministration
• Idelalisib — Strong CYP3A inhibitor; avoid coadministration with sensitive CYP3A4 substrates like ethosuximide
• Isoniazid (for tuberculosis) — May slow ethosuximide metabolism, increasing blood levels. Monitor for ethosuximide toxicity if TB treatment is started.
• Mifepristone — CYP3A4 inhibitor; may increase ethosuximide levels
• Nefazodone — Strong CYP3A4 inhibitor; avoid use with ethosuximide

Interactions That Can Decrease Ethosuximide Levels (Risk of Breakthrough Seizures)

The following drugs induce CYP3A4 and can reduce ethosuximide levels, potentially causing breakthrough seizures:

• Apalutamide (Erleada) — Strong CYP3A4 inducer; avoid coadministration with ethosuximide if possible
• Lumacaftor/ivacaftor (Orkambi) — Strong CYP3A inducer; avoid coadministration with sensitive CYP3A4 substrates
• Rifampicin (rifampin) — Strong CYP3A4 inducer commonly used for TB; significantly increases ethosuximide clearance
• Ivosidenib and Olutasidenib — CYP3A4 inducers; monitor for loss of ethosuximide therapeutic effect

CNS Depressants: Additive Sedation Risk

Ethosuximide can cause drowsiness, and this effect is amplified when combined with other central nervous system (CNS) depressants:

• Alcohol — additive CNS depression; avoid or use extreme caution
• Opioids (e.g., oxycodone, hydrocodone, morphine) — additive sedation
• Benzodiazepines (e.g., clonazepam, diazepam) — additive sedation; may impair psychomotor performance
• Sleep medications, antihistamines, muscle relaxants — additive CNS depression
• Olopatadine intranasal — additive sedation; coadministration increases risk of daytime impairment

Other Notable Interactions

• Metoclopramide intranasal: Each increases the effect of the other through overlapping mechanisms—avoid concurrent use

What to Tell Your Doctor Before Starting Zarontin

Make sure your prescriber knows about ALL medications you take—including:

• All other antiseizure medications
• Antibiotics (especially rifampin or isoniazid)
• Cancer medications and targeted therapies
• Any sleep aids, antihistamines, or pain medications
• Alcohol use patterns
• Supplements and herbal products (St. John's Wort is a CYP3A4 inducer and could reduce ethosuximide levels)

For information about Zarontin's side effects, see our companion guide: Zarontin Side Effects: What to Expect and When to Call Your Doctor.